Andrew Arno - Dec 23, 2022 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
Director
Signature
/s/ Andrew Arno
Stock symbol
OCX
Transactions as of
Dec 23, 2022
Transactions value $
$87,875
Form type
4
Date filed
12/28/2022, 03:05 PM
Previous filing
Aug 22, 2022
Next filing
Jan 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Purchase $87.9K +250K +88.64% $0.35 532K Dec 23, 2022 Direct F1
holding OCX Common Stock, no par value 15K Dec 23, 2022 See footnote F2
holding OCX Common Stock, no par value 15K Dec 23, 2022 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price of $0.3515 per share represents a weighted average of prices ranging from $0.29 to $0.4284 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The shares of common stock are held by JBA Investments LLC. The Reporting Person is the Manager of JBA Investments LLC and in such capacity has the right to vote and dispose of the securities held by such entity.
F3 The shares of common stock are held by MJA Investments LLC. The Reporting Person is the Manager of MJA Investments LLC and in such capacity has the right to vote and dispose of the securities held by such entity.